Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium

Clinical and Experimental Allergy

Volumn 31, Issue 11, 2001, Pages 1705-1713

  Wilson, D R ^a   Irani, A Ma ^b   Walker, S M ^a   Jacobson, M R ^a   Mackay, I S ^a   Schwartz, L B ^c   Durham, S R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic rhinitis; Basophil; Eosinophil; Immunohistochemistry; Immunotherapy; Mast cell; Neutrophil

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; ALLERGIC RHINITIS; ANTIBODY SPECIFICITY; ARTICLE; BASOPHIL; BIOPSY; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; EPITHELIUM; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MALE; MAST CELL; NEUTROPHIL; NOSE MUCOSA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SUBMUCOSA;

ADULT; ALLERGENS; BASOPHILS; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONDON; MALE; MAST CELLS; MIDDLE AGED; NASAL MUCOSA; NEUTROPHILS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TREATMENT OUTCOME;

EID: 0035725164     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01231.x     Document Type: Article

References (41)

1. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: Effect of topical corticosteroids
2. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells
3. Tryptase in nasal fluid is a useful marker of allergic rhinitis
4. Metachromatic cells in nasal mucosa after allergen challenge
5. Allergen-induced changes in the nasal mucous membrane in seasonal allergic rhinitis: Effect of nedocromil sodium
6. Changes in nasal mast cell numbers in and out of the pollen season
7. Development and characterization of a monoclonal antibody specific for human basophils and the identification of a unique secretory product of basophil activation
8. Identification and partial characterisation of a unique marker for human basophils
9. Long-term clinical efficacy of grass-pollen immunotherapy
10. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma
11. Changes in nasal metachromatic cells during allergen immunotherapy
12. Grass pollen immunotherapy decreases the number of mast cells in the skin
13. A biopsy method to obtain high quality specimens of nasal mucosa
14. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils
15. Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomised controlled trial
16. Seasonal variation of nasal surface basophilic cells and eosinophils in Japanese cedar pollinosis
17. The cellular response of the human allergic mucosa to natural allergen exposure
18. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: A biopsy study
19. Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: A comparison of nasal brush and biopsy methods
20. Intraepithelial migration of nasal mucosal mast cells in hay fever
21. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation
22. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation
23. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics
24. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis
25. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation
26. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes
27. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils
28. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation
29. IL-4 production by allergen-stimulated primary cultures: Identification of basophils as the major IL-4-producing cell type
30. CD34 (+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: Potential airway eosinophil progenitors
31. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines
32. Counter-receptors on human basophils for endothelial cell adhesion molecules
33. Circulating basophils in normal subjects and in subjects with hay fever
34. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis
35. Inflammatory mediators in late antigen-induced rhinitis
36. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils
37. Immunohistochemical detection of human basophils in late-phase skin reactions
38. Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment
39. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity
40. Effects of allergen immunotherapy on the nasal mucosa in patients with allergic rhinitis
41. Role of interleukin 10 in specific immunotherapy